Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-14-003044
Filing Date
2014-08-18
Accepted
2014-08-18 17:22:21
Documents
12
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ohrp-10q_063014.htm 10-Q 326400
2 SECOND RESEARCH AMENDMENT ex10-45.htm EX-10.45 86528
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 9428
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 9694
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 5348
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 4404
  Complete submission text file 0001387131-14-003044.txt   2474080

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ohrp-20140630.xml EX-101.INS 239090
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ohrp-20140630.xsd EX-101.SCH 22700
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ohrp-20140630_cal.xml EX-101.CAL 43831
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ohrp-20140630_def.xml EX-101.DEF 75543
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ohrp-20140630_lab.xml EX-101.LAB 194074
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ohrp-20140630_pre.xml EX-101.PRE 147015
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35963 | Film No.: 141049948
SIC: 2834 Pharmaceutical Preparations